digipath

Nevada: DigiPath Inks Deal With First Medical Marijuana Dispensary In Vegas

DigiPathInc(molecular-logo)

DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., on Thursday announced it has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.

Euphoria Wellness, expected to be the first cannabis dispensary to open in Las Vegas, said it chose to partner with DigiPath Labs as part of its strategy to set the highest medical marijuana patient safety and education standards in the industry.

"DigiPath Labs will analyze samples of products sold by Euphoria Wellness for unsafe levels of contaminants such as heavy metals, microbes, mycotoxins, pesticides, and solvents, which can exacerbate patient health issues," says Todd Denkin, president of DigiPath Labs. "We will also quantify cannabinoid and terpenoid levels and deliver detailed reports that Euphoria's staff can use to help patients."

Comprehensive cannabis potency testing is critical for patient care, according to DigiPath. Cannabis is believed to contain over 400 medicinal compounds, most notably cannabinoids and terpenoids, each of which affects the body differently.

One compound, THC, is known to induce cancerous cell death. Another compound, CBD, keeps certain cancers from spreading. Different compounds can reduce tissue inflammation, treat epilepsy, and fight methicillin-resistant staphylococcus aureus (MRSA) infections.

Nevada: Marijuana Testing Facility Opens For Business In Las Vegas

DigiPathLabsCetifiedQualityAndPotencyTestedToNevadaStateStandards

DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., on Wednesday opened the doors of its Las Vegas marijuana analytical testing laboratory for business. Equipped with state of the art analytical instrumentation and operated under the direction of Cindy Orser, PhD, DigiPath Lab's flagship facility says it offers cannabis growers and marijuana-based product-makers fast and reliable results.

"This is a great day for the patients of Nevada who will benefit from medical marijuana," said DigiPath Labs president Todd Denkin. "Our analysis not only helps product producers and dispensaries screen out products with dangerous levels of contaminants, we also quantify the medicinal compounds present in samples, so patients and caregivers can choose products that have been shown to relieve their specific symptoms."

Surprisingly, compulsory cannabis testing is relatively new. The State of Colorado only began requiring product testing a year ago after a series of freakouts on edibles made the news. Washington State did not begin requiring testing for potency, contaminants, moisture and microbiology testing until 2013 when recreational cannabis became legal, even though the medicinal use of marijuana became legal in 1998.

The portfolio of cannabis testing services offered by DigiPath includes foreign matter inspection, moisture content analysis, solvent residue analysis, pesticide residue analysis, heavy metals screening, microbial screening, mycotoxin screening, and potency analysis.

Alaska: Marijuana News Show Now Broadcast On KBYR Anchorage

TNMNews(logo)

TNMNews, which calls itself "the unbiased marijuana talk radio program," is now broadcast on KBYR Anchorage. The announcement follows the news last month that TNMNews is also broadcast on KFAR 660 AM, the oldest radio station in Alaska.

"KBYR has become the third terrestrial station to pick up our unbiased cannabis-related news and talk show," said Todd Denkin, president of TNMNews and CEO of its parent company, DigiPath, Inc. "Cannabis is a hot topic in Alaska, where voters recently gave thumbs up to the recreational use of marijuana by passing Ballot Measure 2."

Hosted by Todd Denkin and Jen Gentile, the latest episode of TNMNews examines how political activism is working to advance acceptance of marijuana use in America and features leaders in the fight to expand cannabis in healthcare and its role in films and television.

First up in this week's show, certified nurse Lanny Swerdlow describes how in 1995 he administered cannabis to a patient for the first time. The patient had contracted HIV/AIDS, and he was wasting away while experiencing severe side effects from his medication cocktail.

Cannabis mitigated the side effects, so Swerdlow's patient stayed compliant with his prescribed medications. It also stimulated the patient's appetite, reversing his wasting, and helped lift his spirits. The problem that Swerdlow faced in treating his patient with marijuana was having to "deal with criminals to get it for him."

U.S.: Show Examines Effects of Filmmakers, Activists, and Entrepreneurs on Marijuana Reform

TNMNews(logo)

The National Marijuana News Corp., a wholly owned subsidiary of DigiPath, Inc., has just released its sixth cannabis news show. Hosted by Todd Denkin and Jen Gentile, the program explores the ways filmmakers, activists, and entrepreneurs shape marijuana public opinion and policy.

Guests include Israeli film producer Lati Grobman, Marijuana Policy Project co-founder Rob Kampia; Seattle Hempfest founder Vivian McPeak; and "pot-trepreneur" Guy Marsala, chairman, CEO, and president of Medbox, Inc.

The show is now available at www.tnmnews.com and at www.Live365.com.

Lati Grobman
Russian-born film producer Lati Grobman kicks off the lineup. She describes her transformation from being an opponent of cannabis legalization to becoming an advocate while producing her documentary Legalize It, which chronicles Proposition 19 and the 2010 campaign to legalize marijuana in California.

"It's a social problem," says Grobman, a mother of five children whose film producer credits include The Iceman and Righteous Kill. "I saw the injustice that is happening. There are people in jail for smoking pot who should not be in jail."

Grobman suggests that resistance to legalizing marijuana partly stems from economic benefits that come with a high rate of incarceration.

Rob Kampia

Nevada: DigiPath Gets State Approval For Cannabis Testing Lab In Las Vegas

DigiPathScientistInLab

DigiPath, Inc., an independent cannabis testing and media firm, on Thursday announced that it has received approval from the state of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas.

DigiPath Labs is in the process of applying for construction permits, ordering equipment, and hiring staff in anticipation of opening the Cameron Street laboratory. To expedite construction, the company is working with a local architectural firm it engaged during the application process. The lab is expected to open its doors to customers in early 2015.

"We are grateful to the State of Nevada for helping to advance our goal of setting a new benchmark for medical cannabis testing and safety screening," said Todd Denkin, CEO of DigiPath, Inc.

"DigiPath Labs is dedicated to increasing transparency of the ingredients inside cannabis-based products," Denkin said. "We believe that this information will benefit patients and dispensaries by providing them with important information regarding the products being sold for consumption."

DigiPath Labs will screen medicinal cannabis for potentially harmful contaminants, including:

• Solvents
• Pesticides
• Mold
• Heavy metals, including mercury, arsenic, lead, and cadmium
• Biological toxins, such as aflatoxin, ricin, and botulinum toxins
• Residual organic chemicals used in extraction
• Microbial contaminants including E. coli, salmonella, and Aspergillus

Syndicate content